Brief: Radiopharm Theranostics Says Via Unit Entered Binding Agreement To Acquire Pharma15 Corp
03/03/2023 24:54
March 3 (Reuters) - Radiopharm Theranostics Ltd
RAD.AX :
* VIA UNIT ENTERED INTO A BINDING AGREEMENT TO ACQUIRE
PHARMA15
CORPORATION
* PURCHASE PRICE UNDER AGREEMENT IS US$4 MILLION
Source text for Eikon: ID:nASX8VQMp4
Further company coverage: RAD.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Radiopharm Theranostics
See all newsBrief: Radiopharm Theranostics Advances To Cohort 3 In 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial
Brief: Radiopharm Theranostics And Siemens Healthineers Sign Clinical Supply Agreement For Rad101 In The U.S.
Brief: Radiopharm Theranostics Says RAD And Siemens Sign Clinical Supply Agreement For Rad101
Brief: Radiopharm Theranostics Doses First Patient In Phase 1/2A Clinical Study Of Betabart
Brief: Radiopharm Theranostics Says Co Increases Ownership In Radiopharm Ventures To 87.5%